West Pharmaceutical Services (WST) Other Non Operating Income (2012 - 2026)
West Pharmaceutical Services (WST) posted quarterly Other Non Operating Income of -$200000.0 for Q2 2026, little changed year-on-year from -$200000.0 in Q2 2025, and little changed on a QoQ basis from -$200000.0 in Q1 2026.
West Pharmaceutical Services (WST) Other Non Operating Income (2012 - 2026) Analysis & Trends
West Pharmaceutical Services (WST) has reported Other Non Operating Income for 12 consecutive years, with -$200000.0 the latest figure, recorded in Q2 2026.
- Quarterly Other Non Operating Income changed 0.0% year-over-year to -$200000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.0 million (up 28.57% YoY) and the FY2025 annual result came in at -$1.0 million, changed 0.0% from the prior year.
- Other Non Operating Income held at -$200000.0 in Q2 2026 per WST's latest filing, from -$200000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for WST reached as high as $3.8 million in Q3 2023 and fell as low as -$49.3 million in Q3 2022.
- A 5-year average of -$3.6 million and a median of -$200000.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 4581.82% — and 2023, when it surged 107.71%.
- Year by year, Other Non Operating Income stood at -$2.2 million in 2022, then surged by 59.09% to -$900000.0 in 2023, then soared by 66.67% to -$300000.0 in 2024, then sank by 33.33% to -$400000.0 in 2025, then jumped by 50.0% to -$200000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$200000.0, -$200000.0, and -$400000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -200,000.00 |
| Mar 31, 2026 | -200,000.00 |
| Dec 31, 2025 | -400,000.00 |
| Sep 30, 2025 | -200,000.00 |
| Jun 30, 2025 | -200,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | -700,000.00 |
| Dec 31, 2023 | -900,000.00 |
| Sep 30, 2023 | 3.80 Mn |
| Jun 30, 2023 | 100,000.00 |
| Dec 31, 2022 | -2.20 Mn |
| Sep 30, 2022 | -49.30 Mn |
| Jun 30, 2022 | 200,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 1.40 Mn |
| Mar 31, 2021 | 1.10 Mn |
| Dec 31, 2020 | 900,000.00 |
| Sep 30, 2020 | 400,000.00 |